Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Putzu · SciRah

Researcher profile · Semantic Scholar

C. Putzu

Share profile

C. Putzu — researcher profile on SciRah

h-index: 15
Works: 45
Citations: 753

Most-cited papers

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab
C. Putzu, D. Cortinovis, F. Colonese, S. Canova +3 more
2018Cancer Immunology and Immunotherapy71 citations
Semantic Scholar
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
G. Palomba, V. Doneddu, A. Cossu, P. Paliogiannis +21 more
2016Journal of Translational Medicine67 citations Open access
Semantic Scholar
Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate.
H. Joensuu, F. D. de Braud, P. Coco, T. De Pas +7 more
2008Annals of Oncology62 citations Open access
Semantic Scholar
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial.
F. Perrone, M. de Laurentiis, S. De Placido, M. Orditura +28 more
2019European Journal of Cancer61 citations Open access
Semantic Scholar
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
A. Passaro, A. Prelaj, L. Bonanno, M. Tiseo +17 more
2019Clinical Lung Cancer56 citations
Semantic Scholar
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).
P. Comella, G. Filippelli, G. De Cataldis, B. Massidda +14 more
2006Annals of Oncology55 citations Open access
Semantic Scholar
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
M. Cazzaniga, Graziella Pinotti, E. Montagna, D. Amoroso +67 more
2019Breast49 citations
Semantic Scholar
Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
C. Putzu, S. Canova, P. Paliogiannis, Renato Lobrano +3 more
2023Cancers41 citations Open access
Semantic Scholar
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
E. Vrdoljak, N. Marschner, C. Zielinski, J. Gligorov +16 more
2016Annals of Oncology36 citations Open access
Semantic Scholar
Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era.
T. De Pas, F. D. de Braud, G. Catalano, C. Putzu +6 more
2007Annals of Thoracic Surgery31 citations
Semantic Scholar
MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia
M. Floris, D. Sanna, P. Castiglia, C. Putzu +13 more
2020BMC Cancer27 citations Open access
Semantic Scholar
Atypical primary pulmonary meningioma: a report of a case suspected of being a lung metastasis
D. Lepanto, F. Maffini, F. Petrella, M. Colandrea +4 more
2014ecancermedicalscience18 citations Open access
Semantic Scholar
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group
P. Comella, V. Lorusso, L. Maiorino, R. Casaretti +11 more
2009Cancer Chemotherapy and Pharmacology18 citations
Semantic Scholar
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
M. Cazzaniga, I. Vallini, E. Montagna, D. Amoroso +45 more
2021Breast Cancer Research and Treatment16 citations Open access
Semantic Scholar
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study
P. Paliogiannis, M. Colombino, M. Sini, A. Manca +20 more
2022BMC Pulmonary Medicine15 citations Open access
Semantic Scholar
Successful outcome after combined chemotherapeutic and surgical management in a case of esophageal cancer with breast and brain relapse.
D. Santeufemia, G. Piredda, G. Fadda, P. Rocca +6 more
2006World Journal of Gastroenterology13 citations Open access
Semantic Scholar
Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women
M. Floris, G. Pira, P. Castiglia, M. Idda +13 more
2022Oncology Letters12 citations Open access
Semantic Scholar
The HOBOE-2 multicenter randomized phase III trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either tamoxifen or letrozole or letrozole + zoledronic acid.
F. Perrone, M. de Laurentiis, S. De Placido, M. Orditura +16 more
2018Annals of Oncology12 citations Open access
Semantic Scholar
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy
C. Putzu, Riccardo Serra, Rachele Campus, Giovanni Maria Fadda +8 more
2024Current Oncology10 citations Open access
Semantic Scholar
KRAS mutations in Non-Small Cell Lung Cancer: translational aspects, current therapies and challenges for future research.
M. Colombino, G. Palomba, M. Casula, M. Pisano +9 more
2025Critical reviews in oncology/hematology9 citations Open access
Semantic Scholar
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A. Gravina, P. Gargiulo, M. de Laurentiis, L. Arenare +23 more
2025ESMO Open9 citations Open access
Semantic Scholar
Bronchial mucoepidermoid carcinoma: A case report
A. Fois, G. Diana, A. Arcadu, Viviana Marras +5 more
2017International journal of surgery case reports8 citations Open access
Semantic Scholar
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial.
P. Comella, V. Chiuri, G. De Cataldis, G. Filippelli +10 more
2010Lung Cancer7 citations
Semantic Scholar
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
B. Trevisan, F. Pepe, I. Vallini, E. Montagna +42 more
2023Scientific Reports6 citations Open access
Semantic Scholar
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature
P. Paliogiannis, C. Putzu, G. C. Ginesu, M. Cossu +8 more
2016Clinical Respiratory Journal6 citations Open access
Semantic Scholar
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
P. Comella, C. Putzu, B. Massidda, G. Condemi +5 more
2007Lung Cancer6 citations
Semantic Scholar
What is the role of QTc prolongation assessment in new drugs development phase I oncology trials?
G. Curigliano, C. Cipolla, C. Sessa, C. Noberasco +6 more
2006Journal of Clinical Oncology6 citations
Semantic Scholar
A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients.
T. De Pas, C. Putzu, G. Curigliano, C. Noberasco +6 more
2006Lung Cancer5 citations
Semantic Scholar
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project
A. De Vito, A. Colpani, M. Mameli, P. Bagella +9 more
2023Infectious Disease Reports4 citations Open access
Semantic Scholar
Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer
P. Comella, B. Massidda, S. Palmeri, C. Putzu +5 more
2006Anti-Cancer Drugs4 citations Open access
Semantic Scholar
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
P. Comella, B. Massidda, D. Natale, C. Putzu +9 more
2011Clinical colorectal cancer3 citations
Semantic Scholar
Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA Study
M. Cazzaniga, P. Pronzato, D. Amoroso, G. Arpino +33 more
2025Cancers2 citations Open access
Semantic Scholar
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study
M. Cazzaniga, P. Pronzato, D. Amoroso, A. Bernardo +38 more
2023Cancers2 citations Open access
Semantic Scholar
Small Cell Lung Cancer in a Young Patient with Osteopetrosis
G. Fadda, D. Santeufemia, P. Rocca, S. Costantino +6 more
2006Tumori2 citations
Semantic Scholar
Psycological di stress in breast cancer patients: pilot study. 6° Meeting Regionale dell'AIOM-associazione italiana oncologia medica. Cagliari (Italy), October 22-23, 2005.
Sanna, L. Lorettu, A. Fancellu, M. Sarobba +5 more
20052 citations
Semantic Scholar
Target-treatment and patients' selection: can we still neglect the timing of tissue collection?
T. De Pas, C. Putzu, G. Pelosi, G. Curigliano +6 more
2005Journal of Clinical Oncology2 citations
Semantic Scholar
Pathophysiological roles, molecular interactions and clinical implications of long non-coding RNA CCAT2 in human cancer
P. Paliogiannis, C. Putzu, A. Fois, P. Pirina +6 more
20171 citations
Semantic Scholar
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature: Paliogiannis et al.
P. Paliogiannis, C. Putzu, G. C. Ginesu, Maria Laura Cossu +8 more
20171 citations
Semantic Scholar
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study.
M. Cazzaniga, L. Orlando, E. Melegari, V. Arcangeli +16 more
2017Annals of Oncology0 citations Open access
Semantic Scholar
Abstract P6-14-01: Final results of the TANIA randomized phase III trial of bevacizumab (BEV) after progression on 1st-line BEV therapy for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
E. Vrdoljak, N. Marschner, C. Zielinski, J. Gligorov +16 more
20160 citations
Semantic Scholar
Razionale all'uso degli inibitori del recettore tirosin-chinasico HER1/EGFR nel trattamento del NSCLC
C. Putzu
20090 citations
Semantic Scholar
Primary Small Cell Bladder Carcinoma
D. Santeufemia, G. Fadda, P. Rocca, G. Sanna +3 more
2007Tumori0 citations
Semantic Scholar
Chemotherapy response evaluation in lung cancer patients: a 99mTC-tetrofosmin SPECT study
A. Spanu, P. Pirina, A. Farris, G. Madeddu +4 more
20070 citations
Semantic Scholar
Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial.
I. Carreca, G. D'Aiuto, L. de Luca, G. Frasci +10 more
20070 citations
Semantic Scholar
Erratum to“A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients” [Lung cancer 54 (2006) 359–364]
T. De Pas, C. Putzu, G. Curigliano, C. Noberasco +6 more
20070 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Paliogiannis×8
Invite
P. Paliogiannis — researcher profile on SciRah
A. Fois×7
Invite
A. Fois — researcher profile on SciRah
F. D. de Braud×6
Invite
F. D. de Braud — researcher profile on SciRah
T. De Pas×6
Invite
T. De Pas — researcher profile on SciRah

×6

Invite

P. Comella — researcher profile on SciRah

Invite

B. Massidda — researcher profile on SciRah

Invite

A. Farris — researcher profile on SciRah

Invite

A. Cossu — researcher profile on SciRah

Invite

G. Sanna — researcher profile on SciRah

M. Cazzaniga×5

Invite

M. Cazzaniga — researcher profile on SciRah

Invite

P. Pirina — researcher profile on SciRah

Invite

C. Carru — researcher profile on SciRah